Financial Performance - Revenue for the reporting period reached RMB 1,001,908,338.30, a 28.04% increase compared to the same period last year[10] - Net profit attributable to shareholders of the listed company was RMB 59,212,576.46, a significant increase of 261.75% year-over-year[10] - Basic earnings per share (EPS) were RMB 0.32, up 260.00% from RMB -0.20 in the same period last year[10] - Weighted average return on equity (ROE) was 2.84%, an increase of 4.77 percentage points compared to the previous year[10] - Total assets as of the end of the reporting period were RMB 3,250,931,157.15, a 1.03% increase from the end of the previous year[10] - Net cash flow from operating activities was RMB 9,160,747.02, a 14.72% increase compared to the same period last year[10] - Revenue for the first half of 2024 reached RMB 1.002 billion, a year-on-year increase of RMB 219 million, up 28.04%[29] - Profit attributable to shareholders of the listed company was RMB 59.2126 million, with a significant improvement in profitability compared to the same period last year[29] - Revenue increased by 28.04% to 1,001,908,338.30 yuan compared to the same period last year[33] - Operating costs rose by 6.34% to 667,659,480.99 yuan[33] - Sales expenses surged by 53.00% to 18,039,417.94 yuan, primarily due to increased market expenses[33] - Financial expenses decreased by 105.43% to -567,924.00 yuan, mainly due to reduced loan interest and foreign exchange hedging business[33] - R&D investment grew by 7.33% to 90,839,933.22 yuan[35] - Net cash flow from operating activities increased by 14.72% to 9,160,747.02 yuan[35] - Net cash flow from investing activities decreased by 174.47% to -166,987,930.70 yuan, mainly due to increased purchase of financial products[35] - Net cash flow from financing activities decreased by 49.01% to -54,223,747.87 yuan, primarily due to reduced repayment of bank loans[35] - Credit impairment loss decreased by 162.52% to -5,423,113.44 yuan, mainly due to provision for bad debts of receivables[35] - Asset impairment loss increased by 166.72% to -90,026,631.47 yuan, mainly due to provision for inventory depreciation[35] - MIM parts and components revenue increased by 32.23% YoY to 643,683,393.59 RMB, with a gross margin of 41.89%[36] - Transmission and heat dissipation components revenue surged by 58.33% YoY to 214,238,092.85 RMB, but gross margin decreased by 9.65% to 15.39%[36] - Investment income reached 2,123,727.51 RMB, accounting for 4.53% of total profit, mainly from financial products and hedging[37] - Asset impairment loss was -90,026,631.47 RMB, representing -192.23% of total profit, primarily due to inventory write-downs[37] - Monetary funds decreased by 37.14% YoY to 405,960,516.07 RMB, mainly due to the purchase of financial products[38] - Accounts receivable increased by 12.10% YoY to 709,224,506.28 RMB, driven by higher revenue[38] - Inventory rose by 47.69% YoY to 451,219,970.30 RMB, mainly due to increased stockpiling[38] - Long-term equity investment surged by 1,606.16% YoY to 7,648,274.94 RMB, due to investment in an affiliated company[38] - GIAN TECH. AMERICA, INC. reported a loss of 166,627.48 RMB, accounting for 0.96% of the company's net assets[40] - Total investment in the reporting period increased by 620% YoY to 7,200,000 RMB[43] - The company invested a total of 10.983 million yuan in two major fixed asset investment projects during the reporting period, with a cumulative investment of 63.376 million yuan[44] - The company's financial derivative investments resulted in a fair value loss of 5.452 million yuan during the reporting period[49] - The company's total entrusted financial management amounted to 115.266 million yuan, with an outstanding balance of 13.818 million yuan[48] - The company's forward exchange settlement and sale business had an initial investment of 32.172 million yuan, with a fair value loss of 426,800 yuan during the reporting period[48] - The company's financial derivative investments accounted for 5.97% of the net assets at the end of the reporting period[48] - The company's total financial assets measured at fair value amounted to 141.735 million yuan at the end of the reporting period[46] - The company's financial derivative investments were primarily for hedging purposes, with no speculative investments during the reporting period[51] - The company's financial derivative investments were sourced from its own funds, with no external financing involved[49] - The company's financial derivative investments were managed under strict internal control measures to mitigate market, liquidity, and operational risks[49] - The company's financial derivative investments were approved by the board of directors on December 7, 2023, and by the shareholders' meeting on December 23, 2023[49][50] - Revenue for the first half of 2024 reached 1,001,908,338.30 RMB, a 28% increase compared to 782,483,727.25 RMB in the same period of 2023[120] - Operating costs for the first half of 2024 were 869,607,715.47 RMB, up 5.7% from 822,983,267.00 RMB in the first half of 2023[121] - R&D expenses increased to 90,839,933.22 RMB in the first half of 2024, a 7.3% rise from 84,639,495.13 RMB in the same period of 2023[121] - Accounts receivable grew to 712,215,436.51 RMB in the first half of 2024, a 13.2% increase from 629,053,730.27 RMB in the first half of 2023[118] - Inventory surged to 318,597,340.10 RMB in the first half of 2024, an 80.5% jump from 176,528,840.16 RMB in the same period of 2023[118] - Total assets slightly decreased to 3,059,564,004.69 RMB in the first half of 2024, down 0.6% from 3,079,379,439.65 RMB in the first half of 2023[118] - Net profit for the first half of 2024 was 46,832,551.99 RMB, a significant improvement from a loss of 51,863,699.71 RMB in the same period of 2023[121] - Short-term borrowings decreased to 91,997,557.23 RMB in the first half of 2024, down 22.1% from 118,119,060.99 RMB in the first half of 2023[118] - Accounts payable increased to 395,738,683.35 RMB in the first half of 2024, a 26.6% rise from 312,455,758.53 RMB in the same period of 2023[119] - Total equity grew to 2,193,370,406.83 RMB in the first half of 2024, a 2% increase from 2,149,620,683.83 RMB in the first half of 2023[119] - Net profit attributable to parent company shareholders was RMB 59.21 million, compared to a loss of RMB 36.61 million in the same period last year[122] - Operating income increased by 46.4% year-over-year to RMB 902.09 million[123] - R&D expenses increased by 7.5% year-over-year to RMB 61.35 million[124] - Operating profit was RMB 74.97 million, a significant improvement from a loss of RMB 34.84 million in the same period last year[124] - Total comprehensive income was RMB 73.52 million, compared to a loss of RMB 28.08 million in the same period last year[125] - Basic earnings per share were RMB 0.32, compared to a loss per share of RMB 0.20 in the same period last year[122] - Interest income increased by 33.1% year-over-year to RMB 3.96 million[124] - Credit impairment losses were RMB 5.04 million, compared to a gain of RMB 18.78 million in the same period last year[124] - Asset impairment losses increased by 153.7% year-over-year to RMB 80.33 million[124] - Other comprehensive income after tax was a loss of RMB 4.04 million, compared to a loss of RMB 1.06 million in the same period last year[125] - Sales revenue from goods and services in H1 2024 was 932.24 million yuan, a slight increase from 925.45 million yuan in H1 2023[126] - Net cash flow from operating activities in H1 2024 was 9.16 million yuan, up from 7.99 million yuan in H1 2023[126] - Cash received from tax refunds in H1 2024 decreased to 10.86 million yuan from 26.09 million yuan in H1 2023[126] - Cash paid for employee compensation increased to 286.17 million yuan in H1 2024 from 270.11 million yuan in H1 2023[126] - Net cash flow from investing activities in H1 2024 was -166.99 million yuan, a significant drop from 224.25 million yuan in H1 2023[127] - Cash received from other investing activities in H1 2024 was 1.23 billion yuan, up from 1.06 billion yuan in H1 2023[127] - Net cash flow from financing activities in H1 2024 was -54.22 million yuan, an improvement from -106.34 million yuan in H1 2023[127] - Cash and cash equivalents at the end of H1 2024 were 398.11 million yuan, down from 605.33 million yuan at the beginning of the period[127] - Parent company's sales revenue from goods and services in H1 2024 was 747.79 million yuan, a decrease from 761.59 million yuan in H1 2023[128] - Parent company's net cash flow from operating activities in H1 2024 was -38.78 million yuan, compared to 26.28 million yuan in H1 2023[128] - Share capital at the beginning of the period was 186,076,681.00 yuan[130] - Capital reserve at the beginning of the period was 1,221,003,318.09 yuan[130] - Other comprehensive income at the beginning of the period was 3,747,996.37 yuan[130] - Undistributed profit at the beginning of the period was 562,061,309.64 yuan[130] - Total owner's equity at the beginning of the period was 2,073,811,464.03 yuan[130] - Comprehensive income for the period decreased by 3,920,990.48 yuan[131] - Owner's equity decreased by 1,112,056.62 yuan due to capital reduction[131] - Total owner's equity at the end of the period was 2,098,218,724.43 yuan[132] - Share capital at the end of the period was 186,076,681.00 yuan[132] - Capital reserve at the end of the period was 1,219,891,261.47 yuan[132] - Comprehensive income for the first half of 2024 was RMB 430,524.54, a significant decrease from the previous period's RMB -36,607,745.82[134] - Owner's equity decreased by RMB 91,466.00 due to capital reduction, with a total reduction of RMB 2,643,947.30[134] - Share-based payments contributed RMB 1,625,234.16 to owner's equity[134] - The ending balance for the period was RMB 186,681.00, with total assets amounting to RMB 1,224,046.27[135] - The company's total owner's equity at the beginning of the period was RMB 2,149,620,683.83[136] - Comprehensive income for the period decreased by RMB 4,035,450.65, impacting the total owner's equity by RMB 73,521,991.96[136] - Profit distribution to owners (or shareholders) amounted to RMB -29,772,268.96[137] - The ending balance for the period was RMB 186,076,681.00, with total owner's equity at RMB 2,193,370,406.83[137] - Total equity at the beginning of the period was RMB 1,941,447,009.57, with a decrease of RMB 26,450,711.26 by the end of the period[139][140] - Comprehensive income for the period showed a loss of RMB 28,075,945.42[139] - The company issued a total of 186,076,681 shares as of June 30, 2024, with a registered capital of RMB 186,076,681[141] - The consolidated financial statements include 14 subsidiaries, with a reduction of 1 subsidiary compared to the previous period[144] - The company's financial statements are prepared in accordance with the Chinese Accounting Standards and the relevant regulations of the China Securities Regulatory Commission[145] - The company's financial statements are based on the assumption of continued operation, with the ability to continue operations for at least 12 months from the end of the reporting period[146] - The company's accounting policies and estimates are tailored to its specific business operations in the metal injection molding industry[147] - The financial statements accurately reflect the company's consolidated and parent company financial position as of June 30, 2024, and the operating results and cash flows for the first half of 2024[148] - The company's accounting period is divided into annual and interim periods, with the fiscal year running from January 1 to December 31[149] - The operating cycle is 12 months, used as the standard for classifying the liquidity of assets and liabilities[150] - The functional currency for the company and its domestic subsidiaries is RMB, while overseas subsidiaries use their local currency as the functional currency[151] - Significant standards for financial reporting include: important accounts receivable write-offs exceeding RMB 500,000, prepayments and payables over 1 year exceeding RMB 5 million, and significant cash flows related to investment and financing activities exceeding RMB 100 million[152] - For business combinations under common control, assets and liabilities are measured at their book value in the consolidated financial statements of the ultimate controlling party[154] - For step-by-step business combinations, transactions are treated as a single transaction if they are part of a package deal, otherwise, adjustments are made to capital reserves[155] - In non-common control business combinations, the acquisition date is when control is transferred, and goodwill is recognized if the purchase consideration exceeds the fair value of identifiable net assets[156] - Costs related to business combinations, such as audit and legal fees, are recognized in the current period's profit and loss[157] - Control is determined based on power over the investee, exposure to variable returns, and the ability to influence returns through power[158] - The consolidation scope includes all subsidiaries controlled by the company, and consolidated financial statements are prepared using uniform accounting policies[159] - The company re-measures the equity held before the acquisition date at fair value, with the difference between fair value and book value recognized as investment income in the current period[162] - Disposal of subsidiaries or businesses results in the inclusion of their income, expenses, profits, and cash flows in the consolidated financial statements up to the disposal date[162] - The company treats multiple transactions for disposing of subsidiary equity as a single transaction if they meet specific conditions, such as being economically interdependent[162] - When purchasing minority equity in a subsidiary, the difference between the new long-term equity investment and the share of net assets is adjusted in the capital reserve[163] - In partial disposals of subsidiary equity without losing control, the difference between the disposal price and the share of net assets is adjusted in the capital reserve[163] - The company classifies joint arrangements as either joint operations or joint ventures based on structure, legal form, and contractual terms[164] - For joint operations, the company recognizes its share of assets, liabilities, revenues, and expenses, and accounts for transactions with other participants accordingly[165] - Cash equivalents are defined as investments with a maturity of three months or less, high liquidity, and minimal value fluctuation risk[166] - Foreign currency transactions are initially recorded at the spot exchange rate on the transaction date, with exchange differences recognized in current period profits[167] - Financial assets or liabilities are recognized when the company becomes a party to the financial instrument contract[169] - Financial assets are classified into three categories: measured at amortized cost, measured at fair value with changes in other comprehensive income, and measured at fair value with changes in current profit or loss[170] - Financial liabilities are initially classified as measured at fair value with changes in current profit or loss or other financial liabilities[171] - Financial assets are derecognized when the contractual rights to the cash flows expire, the asset is transferred with substantially all risks and rewards transferred, or control is relinquished[173] - Financial liabilities are derecognized when the obligation is discharged, replaced with a new liability with substantially different terms, or the terms are substantially modified[174] - Financial assets and liabilities are offset when the company has a legally enforceable right to set off and intends to settle on a net basis or realize the asset and settle the liability simultaneously[175] - Fair value of financial instruments is determined using active market quotes or valuation techniques when no active market exists[176] - Equity instruments are treated as changes in equity, with related transaction costs deducted from equity, and no recognition of fair value changes[178] - The company uses expected credit loss as the basis for recognizing impairment losses on financial assets, including receivables, debt investments, and other financial instruments[179] - For financial assets with significantly increased

Financial Performance - The company expects a net profit attributable to shareholders of approximately 54 million to 61 million RMB for the first half of 2024, compared to a loss of 36.61 million RMB in the same period last year [4]. - The net profit after deducting non-recurring gains and losses is projected to be around 47 million to 54 million RMB, compared to a loss of 46.19 million RMB in the previous year [4]. - The estimated impact of non-recurring gains and losses on net profit for the reporting period is approximately 7 million to 9 million RMB [5]. Revenue and Profitability - The significant improvement in performance is attributed to increased demand from major customers in the metal sector, leading to a notable growth in revenue and enhanced gross profit margin [5]. - The company has strengthened its internal lean operations, effectively improving gross profit margins and overall profitability [5].

证券代码：300709 证券简称：精研科技 公告编号：2024-048 江苏精研科技股份有限公司 关于公司控股股东、实际控制人之一致行动人减持股份的预披露公告 公司控股股东、实际控制人之一致行动人常州创研投资咨询有限公司保证向本公 司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持江苏精研科技股份有限公司（以下简称"公司"）7,623,944 股（占公司 总股本比例 4.10%）的股东常州创研投资咨询有限公司（以下简称"常州创研"）， 计划于本公告披露之日起 15 个交易日之后的 3 个月内，通过集中竞价方式减持 本公司股票的数量不超过 1,860,766 股（占公司总股本比例 1%）。如上述减持期 间内公司有发生除权、除息事项的，减持价格区间及减持股份数量将作相应调整； 如遇公司股票在此期间发生回购注销等股本变动事项的，减持数量将不作相应调 整。 公司董事会于 2024 年 7 月 15 日收到公司控股股东、实际控制人之一致行动 人常州创研（公司上市前的员工持股平台）出具的《股份减持计划告知函》，根 据《 ...

证券代码：300709 证券简称：精研科技 公告编号：2024-046 江苏精研科技股份有限公司（以下简称"公司"）第三届董事会第二十四次 会议审议通过了《关于使用闲置自有资金进行委托理财的议案》，并于 2023 年 12 月 22 日召开公司 2023 年第二次临时股东大会，审议通过了该议案。同意公 司及子公司在商业银行、证券公司等金融机构委托理财，包括但不限于银行理财 产品、资产管理计划等产品及其它根据公司内部决策程序批准的理财对象及理财 方式。单个理财产品的投资期限不超过 12 个月（含），在授权额度内滚动使用。 闲置自有资金进行委托理财的投资金额不超过 10 亿元，在额度内可循环滚动使 用，但任一时点的委托理财金额（含前述投资的收益进行再投资的金额）不得超 过上述投资额度。投资期限自股东大会审议通过之日起 12 个月内有效。针对上 述事项，公司独立董事发表了明确同意的意见。具体内容详见 2023 年 12 月 7 日 在巨潮资讯网（http://www.cninfo.com.cn）上披露的相关公告。 公司于近日使用闲置自有资金 2,000 万元进行了委托理财，现将具体情况公 告如下： 注：该理财产品的 ...

第三届董事会独立董事专门会议 2024 年第一次会议审核意见 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司 独立董事管理办法》、《深圳证券交易所创业板股票上市规则》、《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》以及《江苏精 研科技股份有限公司章程》、《江苏精研科技股份有限公司独立董事制度》等相 关法律法规、规章制度的规定，江苏精研科技股份有限公司（以下简称"公司"） 于 2024 年 5 月 30 日发出会议通知，全体独立董事于 2024 年 6 月 3 日召开独立 董事专门会议 2024 年第一次会议。本次会议由公司过半数独立董事共同推举独 立董事周健主持，独立董事刘永宝、王普查出席。本着谨慎的原则，基于客观、 独立判断的立场，独立董事对公司第三届董事会第二十七次会议的相关事项发表 如下审核意见： 江苏精研科技股份有限公司 （此页无正文，为《江苏精研科技股份有限公司第三届董事会独立董事专门会议 2024 年第一次会议审核意见》之签署页） 独立董事： 周健 刘永宝 王普查 一、关于对外投资设立合伙企业暨关联交易的审核意见 我们认真审阅了《关于对外投资设立合 ...

证券代码：300709 证券简称：精研科技 公告编号：2024-042 江苏精研科技股份有限公司 第三届董事会第二十七次会议决议公告 二、董事会会议审议情况 会议审议并通过了如下议案： 1、审议通过《关于对外投资设立合伙企业暨关联交易的议案》 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、本次董事会会议通知于 2024 年 5 月 30 日通过电子邮件、电话、短信等 形式送达至各位董事，通知中列明了会议的召开时间、地点、内容和方式。 2、本次董事会会议于 2024 年 6 月 3 日在江苏精研科技股份有限公司（以下 简称"公司"）会议室召开，采取通讯方式召开。 3、本次董事会会议应出席董事 7 名，实际出席董事 7 名，均以通讯方式出 席。 4、本次董事会会议由董事长王明喜先生主持，公司监事和高级管理人员以 通讯方式列席了本次董事会。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法 律法规和《公司章程》的有关规定。 江苏精研科技股份有限公司董事会 为满足江苏精研科技股份有限公司（以下简称"公司"）长远战略发展需 ...

证券代码：300709 证券简称：精研科技 公告编号：2024-043 江苏精研科技股份有限公司 第三届监事会第二十五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 1、本次监事会会议通知于 2024 年 5 月 30 日通过电子邮件、电话、短信等 形式送达至各位监事，通知中列明了会议的召开时间、地点、内容和方式。 2、本次监事会会议于 2024 年 6 月 3 日在江苏精研科技股份有限公司（以下 简称"公司"）会议室以通讯表决方式召开。 3、本次监事会会议应出席监事 3 名，实际出席监事 3 名。 4、本次监事会会议由监事会主席施俊先生主持。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法 律法规和《公司章程》的有关规定。 二、监事会会议审议情况 会议审议并通过了如下议案： 1、审议通过《关于对外投资设立合伙企业暨关联交易的议案》 监事会认为：本次公司与关联方共同投资设立合伙企业，对公司长期发展具 有积极影响。本次交易事项的审议及表决程序符合相关法律、法规的规定。交易 各方均以货币出资，交易遵循自愿 ...

证券代码：300709 证券简称：精研科技 公告编号：2024-044 江苏精研科技股份有限公司 关于对外投资设立合伙企业暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、关联交易概述 （一）交易概况 为满足江苏精研科技股份有限公司（以下简称"公司"、"精研科技"）长 远战略发展需要，提升可持续发展能力，公司拟与常州明同管理咨询有限公司（以 下简称"常州明同"）、宁波明研创业投资合伙企业（有限合伙）（以下简称"宁 波明研"）共同设立常州明研志合孵化管理合伙企业（有限合伙）（暂定名，最 终以市场监督管理局核准登记为准，以下简称"明研志合"、"合伙企业"）。 常州明研志合孵化管理合伙企业（有限合伙）总出资额为 1,000 万元人民币，其 中公司拟以货币资金出资 400 万元，占出资额的 40%；常州明同拟以货币资金出 资 1 万元，占出资额的 0.1%；宁波明研拟以货币资金出资 599 万元，占出资额 的 59.9%。 （二）本次交易构成关联交易 本次关联交易共同投资方常州明同和宁波明研均为公司控股股东、实际控制 人之一王明喜先生实际控制的企业 ...

证券代码：300709 证券简称：精研科技 公告编号：2024-041 江苏精研科技股份有限公司 江苏精研科技股份有限公司（以下简称"公司"）董事会于 2024 年 5 月 31 日收到公司副总经理张志俊先生的书面辞职报告。张志俊先生因个人原因向公司 董事会申请辞去公司副总经理职务，原定任期为 2023 年 2 月 6 日至 2024 年 9 月 14 日。辞职后，张志俊先生不在公司担任任何职务。根据《公司法》、《深 圳证券交易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引 第 2 号——创业板上市公司规范运作》及《公司章程》等相关规定，张志俊先生 的辞职报告自送达公司董事会之日起生效，其辞职不会对公司日常经营产生影 响。 截至本公告日，张志俊先生未直接或间接持有公司的股份。张志俊先生的配 偶及其他关联人未持有公司股份。截至目前，张志俊先生不存在应当履行而未履 行的承诺事项。 公司董事会对张志俊先生在任职期间对公司发展所做的贡献表示衷心的感 谢！ 特此公告。 江苏精研科技股份有限公司董事会 2024 年 6 月 1 日 关于高级管理人员辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准 ...

江苏精研科技股份有限公司（以下简称"公司"）第三届董事会第二十四次 会议审议通过了《关于使用闲置自有资金进行委托理财的议案》，并于 2023 年 12 月 22 日召开公司 2023 年第二次临时股东大会，审议通过了该议案。同意公 司及子公司在商业银行、证券公司等金融机构委托理财，包括但不限于银行理财 产品、资产管理计划等产品及其它根据公司内部决策程序批准的理财对象及理财 方式。单个理财产品的投资期限不超过 12 个月（含），在授权额度内滚动使用。 闲置自有资金进行委托理财的投资金额不超过 10 亿元，在额度内可循环滚动使 用，但任一时点的委托理财金额（含前述投资的收益进行再投资的金额）不得超 过上述投资额度。投资期限自股东大会审议通过之日起 12 个月内有效。针对上 述事项，公司独立董事发表了明确同意的意见。具体内容详见 2023 年 12 月 7 日 在巨潮资讯网（http://www.cninfo.com.cn）上披露的相关公告。 公司于近日使用闲置自有资金 4,000 万元进行了委托理财，现将具体情况公 告如下： | 受托人 | 产品名称 | 认购 | 起息日 | 到期日 | 产品 | 预期年化 | ...